OVARIAN SQUAMOUS CELL CARCINOMA
Clinical trials for OVARIAN SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo takes on rare tumors in major trial
Disease control OngoingThis study tests whether combining two immunotherapy drugs, nivolumab and ipilimumab, can shrink tumors in people with rare cancers. About 800 participants with over 50 different rare tumor types received these drugs to boost their immune system's ability to fight cancer. The goa…
Matched conditions: OVARIAN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New hope for rare ovarian cancer: immunotherapy drug tested in small trial
Disease control OngoingThis study tests the drug pembrolizumab in 21 women with a rare and advanced form of ovarian cancer called squamous cell carcinoma. The goal is to see if the drug can shrink tumors or slow the cancer's growth. Participants receive the drug intravenously, and the study tracks how …
Matched conditions: OVARIAN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Niigata University Medical & Dental Hospital • Aim: Disease control
Last updated Jun 08, 2026 13:05 UTC